Revisiting Pfizer's DTCA of Lipitor using Dr. Jarvik as a spokesperson : analyses under the teleological and deontological theories of ethics
Paul Sergius Koku
| Year of publication: |
2022
|
|---|---|
| Authors: | Koku, Paul Sergius |
| Subject: | Direct-to-consumer advertising | ethical implications | ethics | prescription drugs | US | Ethik | Ethics | Arzneimittel | Pharmaceuticals | Unternehmensethik | Business ethics | Wirtschaftsethik | Economic ethics | USA | United States | Direktmarketing | Direct marketing | Theorie | Theory | Werbung | Advertising |
Online Resource
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1080/08911762.2021.1943766 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10012821776